Myocarditis in children and detection of viruses in myocardial tissue: Implications for immunosuppressive therapy

Carregando...
Imagem de Miniatura
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
INTERNATIONAL JOURNAL OF CARDIOLOGY, v.148, n.2, p.204-208, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: There is scarce information on the potential benefits of immunosuppression in children with myocarditis and viral genomes in myocardium. We investigated the occurrence of myocarditis in children with a preliminary diagnosis of dilated cardiomyopathy, the frequency of cardiotropic viruses in the myocardium, and the response to immunosuppression. Methods: Thirty patients (nine months to 12 years) with left ventricular ejection fraction of 22.8 +/- 4.1% were subjected to right cardiac catheterization and endomyocardial biopsy. Specimens were analyzed for the presence of inflammatory elements (Dallas criteria) and viral genome (polymerase chain reaction). Patients with active myocarditis received immunosuppressants (azatioprine and prednisone) and were recatheterized nine months later. A historical control group of nine patients with myocarditis who did not receive immunosuppressants was included. Results: Active myocarditis was diagnosed in ten patients (five with viral genomes detected). Immunosuppression resulted in a significant increase in left ventricular ejection fraction from 25.2 +/- 2.8% to 45.7 +/- 8.6% (versus 20.0 +/- 4.0% to 22.0 +/- 9.0% in historical controls, p < 0.01) and cardiac index from 3.28 +/- 0.51 L/min/m(2) to 4.40 +/- 0.49 L/min/m(2) (versus 3.50 +/- 0.40 L/min/m(2) to 3.70 +/- 0.50 L/min/m(2) in controls, p < 0.01), regardless of the presence of viral genomes (p - 0.98 and p - 0.22, respectively for the two variables). No relevant clinical events were observed. Non-inflammatory cardiomyopathy was diagnosed in 20 patients (seven with viral genomes). While on conventional therapy, there were four deaths and three assignments to transplantation, and no improvement of left ventricular ejection fraction in the remaining ones (22.5 +/- 3.6% to 27.5 +/- 10.6%). Conclusion: Children with chronic myocarditis seem to benefit from immunosuppressive therapy, regardless of the presence of viral genome in the myocardium.
Palavras-chave
Cardiomyopathy, Myocarditis, Polymerase chain reaction, Cardiotropic viruses, Immunosuppressive therapy
Referências
  1. Ahdoot J, 2000, J HEART LUNG TRANSPL, V19, P1118, DOI 10.1016/S1053-2498(00)00179-0
  2. Liu PP, 2001, CIRCULATION, V104, P1076, DOI 10.1161/hc3401.095198
  3. WHY HJF, 1994, CIRCULATION, V89, P2582
  4. Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489
  5. Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048
  6. Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908
  7. Sun YJ, 2003, J MED VIROL, V71, P423, DOI 10.1002/jmv.10502
  8. Mitchell S, 2003, J CLIN VIROL, V26, P331, DOI 10.1016/S1386-6532(02)00082-3
  9. Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.1596231
  10. [Anonymous], 1999, J CARD FAIL, V5, P357
  11. Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
  12. Calabrese F, 2002, DIAGN MOL PATHOL, V11, P212, DOI 10.1097/00019606-200212000-00004
  13. LATHAM RD, 1989, AM HEART J, V117, P876, DOI 10.1016/0002-8703(89)90626-1
  14. ARCHARD LC, 1991, EUR HEART J, V12, P56
  15. Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
  16. CAMARGO PR, 1995, PEDIATR CARDIOL, V16, P61, DOI 10.1007/BF00796819
  17. de Leeuw N, 1999, CLIN INFECT DIS, V29, P522
  18. FENNER TE, 1991, J CLIN MICROBIOL, V29, P2621
  19. Gagliardi MG, 2004, HEART, V90, P1167, DOI 10.1136/hrt.2003.026641
  20. Hia CPP, 2004, ARCH DIS CHILD, V89, P580, DOI 10.1136/adc.2003.034686
  21. Kleinert S, 1997, J HEART LUNG TRANSPL, V16, P1248
  22. MACNAMARA DM, 1999, CIRCULATION S1, V100, P1
  23. Miller AS, 1988, NUCLEIC ACIDS RES, V16, P1215
  24. NARAYAN R, 1991, CLIN CARDIOL, V14, P903
  25. OCONNELL JB, 1981, CIRCULATION, V64, P780
  26. PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601
  27. WEBBER SA, 1994, BRIT HEART J, V72, P360